The High-Resolution Electron Microscopy Facility (HREMF), located t the R.E. """"""""Bob"""""""" Smith Research Building (SRB), is under the direction of Dr. Corazon D. Bucana. The facility houses a Hitachi S520 (>10 years old) scanning electron microscope (SEM) equipped with secondary back-scatter electron detectors, a Micro G isolation table, and a Nova Ultramicrotome and Ultrastainer, and other accessories needed to prepare samples for either SEM or TEM. It also contains ancillary equipment needed for the production of black and white photographs. A Pentium computer with network capabilities and a flatbed scanner allows for electronic transfer of data (images). The well-equipped and staffed facility has allowed the institution to utilize high-resolution electron microscopy without extensive duplication of equipment and services. The facility houses the only SEM on campus, and the other TEMs, located in the Department of Pathology, are dedicated to service and diagnostic purposed with little time for research application. Among the services provided by the facility are: (a) consultation and assistance in the design of experiments to utilize SEM and TEM, (b) conventional processing of samples for SEM and TEM, (c) research and development of novel techniques to meet the demands of individual research projects, and (d) interpretation of data and recommendation for subsequent and future experiments. Further information regarding the facility and availability to investigators can be accessed from M.D. Anderson Home page on the World Wide Web. The HREMF has been operation at its present site since January 1997. The major goal of this facility is to continue to provide a resource to the scientific community at M.D. Anderson Cancer for high-resolution imaging of cells, tissues, organs, or polymers containing anti-cancer agents. Since 1995, 14 departments have utilized both SEM and TEM in their research. The corroborative techniques for light microscopy, fluorescence microscopy, SEM and TEM are often required independently or sequentially. Demand for ultrastructural analysis of apoptosis at both the SEM and TEM levels and the resurgence of morphological characterization of cells, organs, and embryos following genetic manipulation has raised demand for both SEM and TEM.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
3P30CA016672-25S1
Application #
6347266
Study Section
Project Start
2000-08-30
Project End
2001-06-30
Budget Start
Budget End
Support Year
25
Fiscal Year
2000
Total Cost
$254,104
Indirect Cost
Name
University of Texas MD Anderson Cancer Center
Department
Type
DUNS #
001910777
City
Houston
State
TX
Country
United States
Zip Code
77030
Korch, Christopher; Hall, Erin M; Dirks, Wilhelm G et al. (2018) Authentication of M14 melanoma cell line proves misidentification of MDA-MB-435 breast cancer cell line. Int J Cancer 142:561-572
Lee, Jong-Ho; Liu, Rui; Li, Jing et al. (2018) EGFR-Phosphorylated Platelet Isoform of Phosphofructokinase 1 Promotes PI3K Activation. Mol Cell 70:197-210.e7
Brown, Justin C; Troxel, Andrea B; Ky, Bonnie et al. (2018) Dose-response Effects of Aerobic Exercise Among Colon Cancer Survivors: A Randomized Phase II Trial. Clin Colorectal Cancer 17:32-40
Zhang, Hong; Wang, Yirong; Li, Jun et al. (2018) Biosynthetic energy cost for amino acids decreases in cancer evolution. Nat Commun 9:4124
Vilar-Compte, Diana; Shah, Dimpy P; Vanichanan, Jakapat et al. (2018) Influenza in patients with hematological malignancies: Experience at two comprehensive cancer centers. J Med Virol 90:50-60
Bambhroliya, Arvind; Van Wyhe, Renae D; Kumar, Swaminathan et al. (2018) Gene set analysis of post-lactational mammary gland involution gene signatures in inflammatory and triple-negative breast cancer. PLoS One 13:e0192689
Koay, Eugene J; Lee, Yeonju; Cristini, Vittorio et al. (2018) A Visually Apparent and Quantifiable CT Imaging Feature Identifies Biophysical Subtypes of Pancreatic Ductal Adenocarcinoma. Clin Cancer Res 24:5883-5894
Jain, N; Zhu, H; Khashab, T et al. (2018) Targeting nucleolin for better survival in diffuse large B-cell lymphoma. Leukemia 32:663-674
Parker, Patricia A; Peterson, Susan K; Shen, Yu et al. (2018) Prospective Study of Psychosocial Outcomes of Having Contralateral Prophylactic Mastectomy Among Women With Nonhereditary Breast Cancer. J Clin Oncol 36:2630-2638
Fathi, Amir T; Erba, Harry P; Lancet, Jeffrey E et al. (2018) A phase 1 trial of vadastuximab talirine combined with hypomethylating agents in patients with CD33-positive AML. Blood 132:1125-1133

Showing the most recent 10 out of 12418 publications